Litcius/Paper detail

NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD

Michael Seimetz, Natascha Sommer, Mariola Bednorz, Oleg Pak, Christine Veith, Stefan Hadžić, Marija Gredic, Nirmal Parajuli, Baktybek Kojonazarov, Simone Kraut, Jochen Wilhelm, Fenja Knoepp, Ingrid Henneke, Alexandra Pichl, Zeki Ilker Kanbagli, Susan Scheibe, Athanasios Fysikopoulos, Cheng‐Yu Wu, Walter Klepetko, Péter Jaksch, Christina A. Eichstaedt, Ekkehard Grünig, Katrin Hinderhofer, Miklós Geiszt, Niklas Müller, Flávia Rezende, Giulia Buchmann, Ilka Wittig, Matthias Hecker, Andreas Hecker, Winfried Padberg, Peter Dorfmüller, Stefan Gattenlöhner, Claus Vogelmeier, Andreas Günther, Srikanth Karnati, Eveline Baumgart‐Vogt, Ralph T. Schermuly, Hossein Ardeschir Ghofrani, Werner Seeger, Katrin Schröder, Friedrich Grimminger, Ralf P. Brandes, Norbert Weißmann

2020Nature Metabolism40 citationsDOI

Topics & Concepts

PeroxynitriteNADPH oxidaseSuperoxideCOPDNitric oxideNitrotyrosineNitric oxide synthaseKnockout mouseBiologyMolecular biologyChemistryMedicineReactive oxygen speciesBiochemistryInternal medicineEndocrinologyReceptorEnzymeChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsNeonatal Respiratory Health Research
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD | Litcius